Cargando…

FOXA1 in prostate cancer

Most prostate cancers initially respond to androgen deprivation therapy (ADT). With the long-term application of ADT, localized prostate cancer will progress to castration-resistant prostate cancer (CRPC), metastatic CRPC (mCRPC), and neuroendocrine prostate cancer (NEPC), and the transcriptional ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Hui-Yu, Ding, Lei, Zhou, Tian-Ren, Yan, Tao, Li, Jie, Liang, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226509/ https://www.ncbi.nlm.nih.gov/pubmed/36018068 http://dx.doi.org/10.4103/aja202259

Ejemplares similares

Pioneer of prostate cancer: past, present and the future of FOXA1
por: Teng, Mona, et al.
Publicado: (2020)

FOXA1 inhibits prostate cancer neuroendocrine differentiation
por: Kim, Jung, et al.
Publicado: (2017)

Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
por: Zhao, Yu, et al.
Publicado: (2014)

FOXA1 regulates alternative splicing in prostate cancer
por: Del Giudice, Marco, et al.
Publicado: (2022)

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer
por: Gao, Shuai, et al.
Publicado: (2020)

Frequent mutation of the FOXA1 untranslated region in prostate cancer
por: Annala, Matti, et al.
Publicado: (2018)

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
por: Baca, Sylvan C., et al.
Publicado: (2021)

Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
por: Yang, Yeqing Angela, et al.
Publicado: (2015)

Epithelial Transcription Factor FOXA1 Regulates Prostate Cancer Immune Response
por: Brea, Lourdes T, et al.
Publicado: (2021)

Association of Genetic Polymorphisms in FOXA1 with the Progression of Genetic Susceptibility to Gastric Cancer
por: Ding, Guo-wen, et al.
Publicado: (2020)

Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer
por: Celada, Sherly I., et al.
Publicado: (2023)

Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs
por: Maier, Jennifer A., et al.
Publicado: (2013)

Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
por: Parolia, Abhijit, et al.
Publicado: (2019)

FOXA1 mutations alter pioneering activity, differentiation, and prostate cancer phenotypes
por: Adams, Elizabeth J., et al.
Publicado: (2019)

Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer
por: Zhou, Stanley, et al.
Publicado: (2020)

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
por: Zhou, Meng, et al.
Publicado: (2023)

The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH
por: Wang, Ranran, et al.
Publicado: (2015)

FOXA1 defines cancer cell specificity
por: Zhang, Gaihua, et al.
Publicado: (2016)

FoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate Cancer
por: Robinson, Jessica L. L., et al.
Publicado: (2012)

FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
por: Seachrist, Darcie D., et al.
Publicado: (2021)

Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer
por: Lv, Shidong, et al.
Publicado: (2022)

FOXA1 mutations in hormone-dependent cancers
por: Robinson, Jessica L. L., et al.
Publicado: (2013)

Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer
por: Park, Su H., et al.
Publicado: (2021)

THU479 FOXA1 Loss Remodels The Tumor Immune Microenvironment In Late-stage Prostate Cancer
por: Brea, Lourdes T, et al.
Publicado: (2023)

FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
por: Jones, Dominic, et al.
Publicado: (2015)

Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance
por: Domanskyi, Andrii, et al.
Publicado: (2014)

Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression
por: Thanan, Raynoo, et al.
Publicado: (2020)

Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer
por: Jing, Xuan, et al.
Publicado: (2019)

NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
por: Jeter, Collene R, et al.
Publicado: (2016)

Unveiling the Molecular Landscape of FOXA1 Mutant Prostate Cancer: Insights and Prospects for Targeted Therapeutic Strategies
por: Hwang, Kyung Won, et al.
Publicado: (2023)

Twist1 Promotes Breast Cancer Invasion and Metastasis by Silencing Foxa1 Expression
por: Xu, Yixiang, et al.
Publicado: (2016)

FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer
por: Camolotto, Soledad A, et al.
Publicado: (2018)

FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer
por: Wang, Baolei, et al.
Publicado: (2018)

Switch in FOXA1 Status Associates with Endometrial Cancer Progression
por: Tangen, Ingvild Løberg, et al.
Publicado: (2014)

Genome-Wide Location Analysis Reveals Distinct Transcriptional Circuitry by Paralogous Regulators Foxa1 and Foxa2
por: Bochkis, Irina M., et al.
Publicado: (2012)

Pioneer Factors FOXA1 and FOXA2 Assist Selective Glucocorticoid Receptor Signaling in Human Endometrial Cells
por: Whirledge, Shannon, et al.
Publicado: (2017)

Foxa1 and Foxa2 in thymic epithelial cells (TEC) regulate medullary TEC and regulatory T-cell maturation
por: Lau, Ching-In, et al.
Publicado: (2018)

Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence
por: Sunkel, Benjamin, et al.
Publicado: (2016)

Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence
por: Sunkel, Benjamin, et al.
Publicado: (2017)

FOXA1 Promotes Cell Proliferation and Suppresses Apoptosis in HCC by Directly Regulating miR-212-3p/FOXA1/AGR2 Signaling Pathway
por: Yuan, Zhen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c3ecvpll34cisua579bmpbdk3m